Androgen receptor corepressors: An overview
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Androgens play pivotal roles in sex differentiation and development, in reproductive functions, and sexual behavior. The actions of androgens are mediated through the intracellular androgen receptor (AR), a member of the nuclear receptor (NR) superfamily, which regulates a wide range of target gene expression. Recent studies indicate that the proper transcriptional activity of AR is modulated by AR coregulators, including coactivators that can enhance AR transactivation and corepressors that can suppress AR transactivation. Here, we summarize the recent discoveries relating to AR corepressor function with the following different mechanisms: (1) corepressors that inhibit the DNA binding or nuclear translocation of AR; (2) corepressors that recruit histone deacetylases; (3) corepressors that interrupt the interaction between AR and its coactivators; (4) corepressors that interrupt the interaction between the N-terminus and C-terminus of AR; (5) corepressors that function as scaffolds for other AR coregulators; (6) corepressors that target the basal transcriptional machinery; (7) other mechanisms. The potential impact and future directions of AR corepressors are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943 · cited 2×
“On the other hand, androgen is the major growth factor for normal prostate, and the AR signaling pathways play critical roles in the development and progression of prostate cancer [17,124].”
BackgroundSelf-citationZanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., et al. (1994) · Nature · doi:10.1038/372635a0 · Cited by 858
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Self-citationAkt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
Self-citationEvidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
Langley, E., Zhou, Z.-X., & Wilson, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29983 · Cited by 280
Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Cheng, S., Brzostek, S., Lee, S. R., Hollenberg, A. N., & Balk, S. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.7.0870 · Cited by 121
Research works printed but not linked: 120
- Sperling, 1993, J Am Acad Dermatol, 28, 669, 10.1016/0190-9622(93)70092-8 · DOI
- Eder, 2001, Eur Urol, 40, 241, 10.1159/000049782 · DOI
- Chang, 1995, Crit Rev Eukaryot Gene Expr, 5, 97, 10.1615/CritRevEukarGeneExpr.v5.i2.10 · DOI · Paper page
- Roy, 1999, Vitam Horm, 55, 309, 10.1016/S0083-6729(08)60938-3 · DOI · Paper page
- Lyon, 1975, Nature, 258, 620, 10.1038/258620a0 · DOI · Paper page
- Chang, 1988, Science, 240, 324, 10.1126/science.3353726 · DOI · Paper page
- Chang, 1988, Proc Natl Acad Sci USA, 85, 7211, 10.1073/pnas.85.19.7211 · DOI · Paper page
- Kumar, 1999, Steroids, 64, 310, 10.1016/S0039-128X(99)00014-8 · DOI · Paper page
- Roy, 2001, Ann NY Acad Sci, 949, 44, 10.1111/j.1749-6632.2001.tb04001.x · DOI · Paper page
- He, 2000, J Biol Chem, 275, 22986, 10.1074/jbc.M002807200 · DOI · Paper page
- Chang, 1999, Mol Cell Biol, 19, 8226, 10.1128/MCB.19.12.8226 · DOI · Paper page
- Yeh, 1996, Proc Natl Acad Sci USA, 93, 5517, 10.1073/pnas.93.11.5517 · DOI · Paper page
- Kang, 1999, J Biol Chem, 274, 8570, 10.1074/jbc.274.13.8570 · DOI · Paper page
- He, 2002, J Biol Chem, 277, 10226, 10.1074/jbc.M111975200 · DOI · Paper page
- Michalak, 1999, Biochem J, 344, 281, 10.1042/bj3440281 · doi:10.1042/bj3440281 · Paper page
- Dedhar, 1994, Nature, 367, 480, 10.1038/367480a0 · DOI · Paper page
- Burns, 1994, Nature, 367, 476, 10.1038/367476a0 · DOI · Paper page
- Wheeler, 1995, Nucleic Acids Res, 23, 3268, 10.1093/nar/23.16.3268 · DOI
- Zhu, 1998, Endocrinology, 139, 4337, 10.1210/endo.139.10.6242 · doi:10.1210/endo.139.10.6242
- Zhu, 1999, Cancer Res, 59, 1896
- Zhang, 2004, Mol Cell Biol, 24, 1044, 10.1128/MCB.24.3.1044-1057.2004 · DOI
- Zheng, 1998, Proc Natl Acad Sci USA, 95, 14745, 10.1073/pnas.95.25.14745 · DOI · Paper page
- Burris, 1996, Recent Prog Horm Res, 51, 241
- Tamai, 1996, Mol Endocrinol, 10, 1561
- Holter, 2002, Mol Endocrinol, 16, 515, 10.1210/mend.16.3.0804 · doi:10.1210/mend.16.3.0804 · Paper page
- Agoulnik, 2003, J Biol Chem, 278, 31136, 10.1074/jbc.M305153200 · DOI · Paper page
- Yang, 2001, J Biol Chem, 276, 15345, 10.1074/jbc.M010311200 · DOI · Paper page
- Lee, 2002, Mol Endocrinol, 16, 85, 10.1210/mend.16.1.0753 · doi:10.1210/mend.16.1.0753 · Paper page
- Schrantz, 2004, J Biol Chem, 279, 1922, 10.1074/jbc.M311145200 · DOI
- Mathis, 1978, Nucleic Acids Res, 5, 3523, 10.1093/nar/5.10.3523 · DOI
- Xu, 1999, Curr Opin Genet Dev, 9, 140, 10.1016/S0959-437X(99)80021-5 · DOI · Paper page
- Brady, 1999, J Biol Chem, 274, 17599, 10.1074/jbc.274.25.17599 · DOI · Paper page
- Ma, 1999, Mol Cell Biol, 19, 6164, 10.1128/MCB.19.9.6164 · DOI · Paper page
- Fu, 2000, J Biol Chem, 275, 20853, 10.1074/jbc.M000660200 · DOI · Paper page
- Wang, 2001, J Biol Chem, 276, 7493, 10.1074/jbc.M009916200 · DOI · Paper page
- Gu, 1997, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- Sartorelli, 1999, Mol Cell, 4, 725, 10.1016/S1097-2765(00)80383-4 · DOI · Paper page
- Mal, 2001, EMBO J, 20, 1739, 10.1093/emboj/20.7.1739 · DOI · Paper page
- Luo, 2000, Nature, 408, 377, 10.1038/35042612 · DOI · Paper page
- Gaughan, 2002, J Biol Chem, 277, 25904, 10.1074/jbc.M203423200 · DOI · Paper page
- Wotton, 1999, Cell, 97, 29, 10.1016/S0092-8674(00)80712-6 · DOI · Paper page
- Bertolino, 1995, J Biol Chem, 270, 31178, 10.1074/jbc.270.52.31178 · DOI · Paper page
- Sharma, 2001, Mol Endocrinol, 15, 1918
- Jeong, 2004, Mol Endocrinol, 18, 13, 10.1210/me.2003-0065 · DOI · Paper page
- Niki, 2003, Mol Cancer Res, 1, 247
- Privalsky, 2001, Curr Top Microbiol Immunol, 254, 117, 10.1007/978-3-662-10595-5_6 · DOI
- Ordentlich, 2001, Curr Top Microbiol Immunol, 254, 101, 10.1007/978-3-662-10595-5_5 · DOI
- Wagner, 1998, Mol Cell Biol, 18, 1369, 10.1128/MCB.18.3.1369 · DOI · Paper page
- Huang, 2002, Mol Endocrinol, 16, 1778, 10.1210/me.2002-0089 · DOI · Paper page
- Jackson, 1997, Mol Endocrinol, 11, 693, 10.1210/mend.11.6.0004 · doi:10.1210/mend.11.6.0004 · Paper page
- Dotzlaw, 2002, Mol Endocrinol, 16, 661, 10.1210/mend.16.4.0798 · doi:10.1210/mend.16.4.0798 · Paper page
- Liao, 2003, J Biol Chem, 278, 5052, 10.1074/jbc.M206374200 · DOI · Paper page
- Huang, 2002, Mol Endocrinol, 16, 924, 10.1210/mend.16.5.0829 · doi:10.1210/mend.16.5.0829 · Paper page
- Seol, 1997, Mol Cell Biol, 17, 7126, 10.1128/MCB.17.12.7126 · DOI · Paper page
- Johansson, 1999, J Biol Chem, 274, 345, 10.1074/jbc.274.1.345 · DOI · Paper page
- Seol, 1998, Mol Endocrinol, 12, 1551, 10.1210/mend.12.10.0184 · DOI · Paper page
- Johansson, 2000, Mol Cell Biol, 20, 1124, 10.1128/MCB.20.4.1124-1133.2000 · DOI · Paper page
- Gobinet, 2001, Biochemistry, 40, 15369, 10.1021/bi011384o · DOI · Paper page
- Wen, 2000, Cancer Res, 60, 6841
- Li, 2001, J Biol Chem, 276, 20444, 10.1074/jbc.M010226200 · DOI · Paper page
- Lin, 2003, J Biol Chem, 278, 50902, 10.1074/jbc.M300676200 · DOI · Paper page
- Lin, 2002, EMBO J, 21, 4037, 10.1093/emboj/cdf406 · DOI · Paper page
- Petre-Draviam, 2003, Cancer Res, 63, 4903
- Petre, 2002, J Biol Chem, 277, 2207, 10.1074/jbc.M106399200 · DOI · Paper page
- Reutens, 2001, Mol Endocrinol, 15, 797, 10.1210/mend.15.5.0641 · doi:10.1210/mend.15.5.0641 · Paper page
- Knudsen, 1999, Cancer Res, 59, 2297
- Coqueret, 2002, Gene, 299, 35, 10.1016/S0378-1119(02)01055-7 · DOI · Paper page
- Drobnjak, 2000, Clin Cancer Res, 6, 1891
- Derynck, 1998, Cell, 95, 737, 10.1016/S0092-8674(00)81696-7 · DOI · Paper page
- Matsuda, 2001, J Biol Chem, 276, 42908, 10.1074/jbc.M105316200 · DOI · Paper page
- Subramaniam, 2001, J Biol Chem, 276, 15741, 10.1074/jbc.M011033200 · DOI
- Hayes, 2001, Cancer Res, 61, 2112
- Chipuk, 2002, J Biol Chem, 277, 1240, 10.1074/jbc.M108855200 · DOI · Paper page
- Kang, 2001, Proc Natl Acad Sci USA, 98, 3018, 10.1073/pnas.061305498 · DOI · Paper page
- Kang, 2002, J Biol Chem, 277, 43749, 10.1074/jbc.M205603200 · DOI · Paper page
- Stossel, 2001, Nat Rev Mol Cell Biol, 2, 138, 10.1038/35052082 · DOI · Paper page
- Loy, 2003, Proc Natl Acad Sci USA, 100, 4562, 10.1073/pnas.0736237100 · DOI · Paper page
- Wang, 2004, Mol Cell Biol, 24, 2202, 10.1128/MCB.24.5.2202-2213.2004 · DOI · Paper page
- Cohen, 1978, Biochem Soc Symp, 43, 69
- Sears, 2000, Genes Dev, 14, 2501, 10.1101/gad.836800 · DOI · Paper page
- de Groot, 1993, Oncogene, 8, 841
- Rogatsky, 1998, J Biol Chem, 273, 14315, 10.1074/jbc.273.23.14315 · DOI · Paper page
- Wang, 2004, J Biol Chem, 279, 32444, 10.1074/jbc.M313963200 · DOI · Paper page
- Ron, 1999, J Biol Chem, 274, 27039, 10.1074/jbc.274.38.27039 · DOI · Paper page
- Rigas, 2003, J Biol Chem, 278, 46087, 10.1074/jbc.M306219200 · DOI · Paper page
- Gross, 2001, Oncogene, 20, 3880, 10.1038/sj.onc.1204489 · DOI · Paper page
- McEwan, 1997, Proc Natl Acad Sci USA, 94, 8485, 10.1073/pnas.94.16.8485 · DOI · Paper page
- Lee, 2000, J Biol Chem, 275, 9308, 10.1074/jbc.275.13.9308 · DOI · Paper page
- Chen, 2000, Gene, 249, 1, 10.1016/S0378-1119(00)00161-X · DOI · Paper page
- Javed, 2000, J Cell Sci, 113, 2221, 10.1242/jcs.113.12.2221 · DOI · Paper page
- Tetsuka, 2000, J Biol Chem, 275, 4383, 10.1074/jbc.275.6.4383 · DOI · Paper page
- Choudhury, 1997, Gene, 195, 41, 10.1016/S0378-1119(97)00150-9 · doi:10.1016/s0378-1119(97)00150-9
- Yu, 2001, Mol Cell Biol, 21, 4614, 10.1128/MCB.21.14.4614-4625.2001 · DOI · Paper page
- Iizuka, 1999, J Biol Chem, 274, 23027, 10.1074/jbc.274.33.23027 · DOI · Paper page
- Sharma, 2000, J Biol Chem, 275, 35200, 10.1074/jbc.M004838200 · DOI · Paper page
- Cantley, 1999, Proc Natl Acad Sci USA, 96, 4240, 10.1073/pnas.96.8.4240 · DOI · Paper page
- Vlietstra, 1998, Cancer Res, 58, 2720
- Cairns, 1997, Cancer Res, 57, 4997
- Lin, 2004, Mol Endocrinol
- Peters, 1995, Biochemistry, 34, 4569, 10.1021/bi00014a009 · doi:10.1021/bi00014a009
- Harley, 1994, Nucleic Acids Res, 22, 1500, 10.1093/nar/22.8.1500 · DOI · Paper page
- Poulat, 1995, J Cell Biol, 128, 737, 10.1083/jcb.128.5.737 · doi:10.1083/jcb.128.5.737
- Lamb, 1995, World J Urol, 13, 277, 10.1007/BF00185970 · DOI
- Yuan, 2001, J Biol Chem, 276, 46647, 10.1074/jbc.M108404200 · DOI · Paper page
- Chang, 1994, Proc Natl Acad Sci USA, 91, 6040, 10.1073/pnas.91.13.6040 · DOI
- Chang, 1989, Biochem Biophys Res Commun, 165, 735, 10.1016/S0006-291X(89)80028-2 · DOI
- Lee, 1999, Proc Natl Acad Sci USA, 96, 14724, 10.1073/pnas.96.26.14724 · DOI · Paper page
- Mu, 2003, Prostate, 57, 129, 10.1002/pros.10282 · DOI
- Sun, 1999, Cancer, 86, 689, 10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P · DOI · Paper page
- McKay, 1998, Mol Endocrinol, 12, 45, 10.1210/mend.12.1.0044 · DOI · Paper page
- Supakar, 1995, J Biol Chem, 270, 837, 10.1074/jbc.270.2.837 · DOI · Paper page
- McKay, 1999, Endocr Rev, 20, 435
- Griffin, 1992, N Engl J Med, 326, 611, 10.1056/NEJM199202273260906 · DOI · Paper page
- Warner, 1992, Neurology, 42, 2181, 10.1212/WNL.42.11.2181 · doi:10.1212/wnl.42.11.2181
- Quigley, 1995, Endocr Rev, 16, 271
- Grino, 1988, J Clin Endocrinol Metab, 66, 754, 10.1210/jcem-66-4-754 · DOI
- Isaacs, 1994, Vitam Horm, 49, 433, 10.1016/S0083-6729(08)61152-8 · DOI
- Greenlee, 2000, CA Cancer J Clin, 50, 7, 10.3322/canjclin.50.1.7 · DOI · Paper page
- Prostate Cancer Trialists' Collaborative Group, 1995, Lancet, 346, 265, 10.1016/S0140-6736(95)92163-X · DOI · Paper page
- Thalmann, 1994, Cancer Res, 54, 2577
Cited by
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer
Pienta, K. J., & Bradley, D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0067 · Cited by 430
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
The role of androgen receptor mutations in prostate cancer progression.
Brooke, G., & Bevan, C. (2009) · Current Genomics · doi:10.2174/138920209787581307 · Cited by 181
“There are multiple mechanisms by which corepressors appear to inhibit receptor signalling - for example, via recruitment of histone deacetylases to condense chromatin structure, and via nuclear exclusion of the receptor [49].”
Background
Metadata
- Authors
- Wang, L., Hsu, C.-L., & Chang, C.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2005
- Volume
- 63
- Issue
- 2
- Pages
- 117-130
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2107850854
- Cited by
- 115
- References
- 8
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3895 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.